Literature DB >> 11834250

cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation.

Jos Prickaerts1, Jan de Vente, Wiel Honig, Harry W M Steinbusch, Arjan Blokland.   

Abstract

The present study investigates the role of cGMP and cAMP on the memory performance in the object recognition task in rats. The analogue 8-Br-GMP or 8-Br-cAMP was administered bilaterally into the hippocampus (0, 1, 3 and 10 microg in 0.5 microl saline/site) immediately after the exposure to two identical objects. After 24 h, saline-treated animals spent equal times exploring a new and the familiar object demonstrating that they did not recognize the familiar one. However, a dose-dependent improvement in object recognition was found after injection of 8-Br-cGMP. In contrast, 8-Br-cAMP did not improve the memory performance at the doses tested. These results indicate that hippocampal cGMP but not cAMP is involved in early stages of consolidation of object memory.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834250     DOI: 10.1016/s0014-2999(01)01614-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  35 in total

1.  The Phosphodiesterase 9 Inhibitor PF-04449613 Promotes Dendritic Spine Formation and Performance Improvement after Motor Learning.

Authors:  Baoling Lai; Miao Li; Wanling Hu; Wei Li; Wen-Biao Gan
Journal:  Dev Neurobiol       Date:  2018-07-18       Impact factor: 3.964

2.  Acute tryptophan depletion in accordance with body weight: influx of amino acids across the blood-brain barrier.

Authors:  V L S Dingerkus; T J Gaber; K Helmbold; S Bubenzer; A Eisert; C L Sánchez; F D Zepf
Journal:  J Neural Transm (Vienna)       Date:  2012-05-24       Impact factor: 3.575

3.  Structure-Based Design of a Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target Engagement.

Authors:  Peter Buijnsters; Meri De Angelis; Xavier Langlois; Frederik J R Rombouts; Wendy Sanderson; Gary Tresadern; Alison Ritchie; Andrés A Trabanco; Greet VanHoof; Yves Van Roosbroeck; José-Ignacio Andrés
Journal:  ACS Med Chem Lett       Date:  2014-07-22       Impact factor: 4.345

4.  Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease.

Authors:  Min Sheng; Hanzhang Lu; Peiying Liu; Yang Li; Harshan Ravi; Shin-Lei Peng; Ramon Diaz-Arrastia; Michael D Devous; Kyle B Womack
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease.

Authors:  M Cuadrado-Tejedor; I Hervias; A Ricobaraza; E Puerta; J M Pérez-Roldán; C García-Barroso; R Franco; N Aguirre; A García-Osta
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

6.  Pharmacological modulators of nitric oxide signaling and contextual fear conditioning in mice.

Authors:  Jonathan B Kelley; Karen L Anderson; Yossef Itzhak
Journal:  Psychopharmacology (Berl)       Date:  2010-03-12       Impact factor: 4.530

7.  Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study.

Authors:  Y S Shim; C-U Pae; K J Cho; S W Kim; J C Kim; J S Koh
Journal:  Int J Impot Res       Date:  2013-11-28       Impact factor: 2.896

8.  Improved long-term memory via enhancing cGMP-PKG signaling requires cAMP-PKA signaling.

Authors:  Eva Bollen; Daniela Puzzo; Kris Rutten; Lucia Privitera; Jochen De Vry; Tim Vanmierlo; Gunter Kenis; Agostino Palmeri; Rudi D'Hooge; Detlef Balschun; Harry M W Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Neuropsychopharmacology       Date:  2014-05-12       Impact factor: 7.853

Review 9.  Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

Authors:  Olga A H Reneerkens; Kris Rutten; Harry W M Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

10.  A placebo-controlled study of sildenafil effects on cognition in schizophrenia.

Authors:  Donald C Goff; Corinne Cather; Oliver Freudenreich; David C Henderson; A Eden Evins; Melissa A Culhane; Jared P Walsh
Journal:  Psychopharmacology (Berl)       Date:  2008-08-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.